Dr. Chandler Park discusses the importance of genetic testing and personalized care in patients with genitourinary cancers.

Proactive onco-coaching did not improve quality of life but was linked to better overall survival in patients with metastatic ...

Dana-Farber Cancer Institute researchers will present important research studies during the 2025 ASCO Genitourinary (GU) ...

Cade, Telix Group Chief Medical Officer, said, “Telix will feature in four presentations at this year’s ASCO GU, which showcase the depth and differentiation of our therapeutic urologic pipeline, ...

A recent meta-analysis shows that acute toxicities following radiation therapy signal a greater risk for later complications in patients with prostate cancer.